back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-25 16:55 Tx date 2024-03-21 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,100
+35,000 vol $0.06 each |
795,000 | |
| Filed 2024-03-25 16:49 Tx date 2024-03-21 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,100
-35,000 vol $0.06 each |
490,000 | |
| Filed 2023-05-16 16:43 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
525,000 | |
| Filed 2023-03-16 12:14 Tx date 2023-03-13 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,000
+200,000 vol $0.10 each |
760,000 | |
| Filed 2023-03-16 12:11 Tx date 2023-03-13 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,000
-200,000 vol $0.10 each |
325,000 | |
| Filed 2022-08-12 16:34 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
525,000 | |
| Filed 2021-09-22 13:46 Tx date 2021-07-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$42,000
+280,000 vol $0.15 each |
560,000 | |
| Filed 2021-09-22 13:42 Tx date 2021-07-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-42,000
-280,000 vol $0.15 each |
0 | |
| Filed 2021-09-22 13:27 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-42,000
-280,000 vol $0.15 each |
||
| Filed 2021-04-19 22:11 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
400,000 | |
| Filed 2021-04-19 21:59 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
400,000 | |
| Filed 2021-04-19 21:59 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:54 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:54 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2019-10-31 21:05 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
325,000 | |
| Filed 2019-08-16 23:49 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$42,000
+280,000 vol $0.15 each |
280,000 | |
| Filed 2019-08-16 23:47 Tx date 2018-03-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:47 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$14,000
+280,000 vol $0.05 each |
280,000 | |
| Filed 2019-08-16 23:46 Tx date 2018-03-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-13 10:52 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100
+35,000 vol $0.06 each |
235,000 | |
| Filed 2018-03-27 Tx date 2018-03-21 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-27 Tx date 2018-03-27 |
$VANC
Vanc Pharmaceuticals Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+200,000 vol $0.24 each |
200,000 |